These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3134900)

  • 1. [Gene technology in the diagnosis of viruses and vaccine development].
    Löwer J
    Arzneimittelforschung; 1988 Mar; 38(3A):438-41. PubMed ID: 3134900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in viral vaccine development.
    Brown F
    Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viruses and gene engineering].
    Tikhonenko TI
    Vestn Akad Med Nauk SSSR; 1983; (12):67-75. PubMed ID: 6198816
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?
    Bukreyev A; Belyakov IM
    Expert Rev Vaccines; 2002 Aug; 1(2):233-45. PubMed ID: 12901562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Jenner to genes--the next generation of virus vaccines.
    Brown F
    Biochem Soc Symp; 1987; 53():75-84. PubMed ID: 3332769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of dengue vaccines and prospects for the future.
    Bancroft WH
    P R Health Sci J; 1987 Apr; 6(1):23-6. PubMed ID: 3615797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
    Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
    Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant DNA technology for the preparation of subunit vaccines.
    Bachrach HL
    J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.
    Connors M; Crowe JE; Firestone CY; Murphy BR; Collins PL
    Virology; 1995 Apr; 208(2):478-84. PubMed ID: 7747420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus.
    Jones L; Tenorio E; Gorham J; Yilma T
    Am J Vet Res; 1997 Jun; 58(6):590-3. PubMed ID: 9185963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.
    Witko SE; Kotash CS; Nowak RM; Johnson JE; Boutilier LA; Melville KJ; Heron SG; Clarke DK; Abramovitz AS; Hendry RM; Sidhu MS; Udem SA; Parks CL
    J Virol Methods; 2006 Jul; 135(1):91-101. PubMed ID: 16569439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered viral vaccines--prospects for the future.
    Pettersson RF
    Ann Clin Res; 1982 Dec; 14(5-6):245-52. PubMed ID: 6763495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral vaccines: achievements and challenges.
    Melnick JL
    Acta Virol; 1989 Sep; 33(5):482-93. PubMed ID: 2576588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.
    Koenig P; Hoffmann B; Depner KR; Reimann I; Teifke JP; Beer M
    Vet Microbiol; 2007 Mar; 120(3-4):343-51. PubMed ID: 17147979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of virus mutations caused by passages on vaccinal immunogenicity].
    Kato A
    Nihon Rinsho; 2008 Oct; 66(10):1908-14. PubMed ID: 18939489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.